IPAD-DB ID | C00169 |
Name | Tamarixetin |
Category | Natural compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 6 H 1 2 O 7 |
Molecular Weight | 316.26g/mol |
IUPAC Name | 3, 5, 7-trihydroxy-2-(3-hydroxy-4-methoxyphenyl)chromen-4-one |
InChI | InChI=1S/C16H12O7/c1-22-11-3-2-7(4-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6, 17-19, 21H, 1H3 |
InChIKey | FPLMIPQZHHQWHN-UHFFFAOYSA-N |
Canonical SMILES | COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
PubChem CID | 5281699 |
DrugBank Accession Number | - |
CAS Registry Number | 603-61-2 |
Molecular Weight(Computed by SwissADME) | 316.26 |
Hac(Computed by SwissADME) | 23 |
Volume(Computed by ADMETlab 2.0) | 300.063 |
Density(Computed by ADMETlab 2.0) | 1.053 |
nRing(Computed by ADMETlab 2.0) | 3 |
MaxRing(Computed by ADMETlab 2.0) | 10 |
nHet(Computed by ADMETlab 2.0) | 7 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 18 |
Flexibility(Computed by ADMETlab 2.0) | 0.111 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.74 |
LogD(Computed by ADMETlab 2.0) | 2.308 |
logP(Computed by ADMETlab 2.0) | 2.29 |
TPSA(Computed by SwissADME) | 120.36 Ų |
Hbond Acceptor(Computed by SwissADME) | 7 |
Hbond Donor(Computed by SwissADME) | 4 |
Rotatable Bonds(Computed by SwissADME) | 2 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | Yes |
CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
log Kp(Skin Permeation)(Computed by SwissADME) | -6.13 cm/s |
Lipinski(Computed by SwissADME) | Yes, 0 violation |
Ghose(Computed by SwissADME) | Yes |
Veber(Computed by SwissADME) | Yes |
Egan(Computed by SwissADME) | Yes |
Muegge(Computed by SwissADME) | Yes |
Bioavailability Score(Computed by SwissADME) | 0.55 |